How has been the historical performance of Medinova Diagno.?

Answer:The historical performance of Medinova Diagno shows fluctuations in key financial metrics over the years.

Breakdown:
Medinova Diagno's net sales have experienced a decline from 13.20 Cr in March 2022 to 9.81 Cr in March 2025, with a slight increase in March 2023 to 9.99 Cr. Total operating income followed a similar trend, peaking at 13.20 Cr in March 2022 and decreasing to 9.81 Cr in March 2025. The total expenditure, excluding depreciation, has also decreased from 9.49 Cr in March 2022 to 6.82 Cr in March 2025. Operating profit (PBDIT) has shown some improvement, rising from 1.27 Cr in March 2020 to 3.14 Cr in March 2025, although it peaked at 3.86 Cr in March 2022. Profit before tax has increased from a loss of 0.28 Cr in March 2020 to a profit of 2.50 Cr in March 2025. However, profit after tax has seen a decline from 2.38 Cr in March 2022 to 1.90 Cr in March 2025. The company's net profit has fluctuated, with a notable loss of 0.23 Cr in March 2020, recovering to 1.90 Cr in March 2025. The total liabilities have increased from 4.56 Cr in March 2019 to 4.91 Cr in March 2024, while total assets have also risen from 4.56 Cr in March 2019 to 4.91 Cr in March 2024. Cash flow from operating activities has remained stable at 1.00 Cr from March 2021 to March 2023, with a notable increase to 2.00 Cr in March 2024. Overall, Medinova Diagno has shown resilience in profitability despite challenges in sales and fluctuating expenses.